US Stock MarketDetailed Quotes

NVCT Nuvectis Pharma

Watchlist
  • 6.740
  • +0.020+0.30%
Close Jul 22 16:00 ET
123.72MMarket Cap-4780P/E (TTM)

Nuvectis Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
8.77%-4.36M
-17.66%-15.95M
-9.50%-3.85M
26.67%-3.24M
-60.56%-4.08M
-55.30%-4.78M
-42.67%-13.56M
-229.52%-3.52M
0.05%-4.42M
36.60%-2.54M
Net income from continuing operations
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
-25.90%-5.88M
39.90%-3.57M
Change In working capital
30.38%-1.48M
-58.08%1.6M
-42.48%1.55M
68.23%1.5M
30.81%675K
-637.02%-2.13M
155.62%3.82M
167.39%2.7M
743.40%894K
44.94%516K
-Change in payables and accrued expense
28.30%-1.29M
-69.86%1.25M
-25.27%1.41M
-6.05%1.37M
6.15%276K
-432.47%-1.8M
161.20%4.14M
71.27%1.88M
1,271.70%1.45M
-26.97%260K
-Change in other current assets
41.77%-191K
209.97%353K
-82.31%144K
124.64%138K
55.86%399K
60.53%-328K
-252.75%-321K
994.51%814K
---560K
--256K
Cash from discontinued investing activities
Operating cash flow
8.77%-4.36M
-17.66%-15.95M
-9.50%-3.85M
26.67%-3.24M
-60.56%-4.08M
-55.30%-4.78M
-42.67%-13.56M
-229.52%-3.52M
0.05%-4.42M
36.60%-2.54M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
1,763.49%4.7M
-45.75%15.09M
800.00%917K
-95.15%703K
2,386.33%13.22M
-98.20%252K
82.41%27.81M
-131K
260.41%14.49M
-105.15%-578K
Net common stock issuance
--4.85M
-83.41%5.29M
--901K
-92.91%1.13M
--3.26M
--0
--31.88M
--0
--15.88M
--0
Proceeds from stock option exercised by employees
--0
--11.19M
--0
--14K
--10.48M
--702K
--0
--0
--0
--0
Net other financing activities
66.00%-153K
65.74%-1.39M
112.21%16K
68.49%-437K
9.52%-523K
77.19%-450K
---4.07M
---131K
---1.39M
---578K
Cash from discontinued financing activities
Financing cash flow
1,763.49%4.7M
-45.75%15.09M
800.00%917K
-95.15%703K
2,386.33%13.22M
-98.20%252K
82.41%27.81M
---131K
260.41%14.49M
-105.15%-578K
Net cash flow
Beginning cash position
-4.34%19.13M
248.19%19.99M
-6.69%22.06M
81.26%24.6M
-7.34%15.47M
248.19%19.99M
--5.74M
247.19%23.64M
88.13%13.57M
--16.69M
Current changes in cash
107.47%338K
-106.08%-867K
19.58%-2.93M
-125.24%-2.54M
392.60%9.13M
-141.32%-4.53M
148.19%14.25M
-241.80%-3.65M
2,585.93%10.07M
---3.12M
End cash Position
25.83%19.46M
-4.34%19.13M
-4.34%19.13M
-6.69%22.06M
81.26%24.6M
-7.34%15.47M
248.19%19.99M
248.19%19.99M
247.19%23.64M
88.13%13.57M
Free cash flow
8.77%-4.36M
-17.66%-15.95M
-9.50%-3.85M
26.67%-3.24M
-60.56%-4.08M
-55.30%-4.78M
-42.67%-13.56M
-229.52%-3.52M
0.05%-4.42M
36.60%-2.54M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 8.77%-4.36M-17.66%-15.95M-9.50%-3.85M26.67%-3.24M-60.56%-4.08M-55.30%-4.78M-42.67%-13.56M-229.52%-3.52M0.05%-4.42M36.60%-2.54M
Net income from continuing operations -3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M-25.90%-5.88M39.90%-3.57M
Change In working capital 30.38%-1.48M-58.08%1.6M-42.48%1.55M68.23%1.5M30.81%675K-637.02%-2.13M155.62%3.82M167.39%2.7M743.40%894K44.94%516K
-Change in payables and accrued expense 28.30%-1.29M-69.86%1.25M-25.27%1.41M-6.05%1.37M6.15%276K-432.47%-1.8M161.20%4.14M71.27%1.88M1,271.70%1.45M-26.97%260K
-Change in other current assets 41.77%-191K209.97%353K-82.31%144K124.64%138K55.86%399K60.53%-328K-252.75%-321K994.51%814K---560K--256K
Cash from discontinued investing activities
Operating cash flow 8.77%-4.36M-17.66%-15.95M-9.50%-3.85M26.67%-3.24M-60.56%-4.08M-55.30%-4.78M-42.67%-13.56M-229.52%-3.52M0.05%-4.42M36.60%-2.54M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 1,763.49%4.7M-45.75%15.09M800.00%917K-95.15%703K2,386.33%13.22M-98.20%252K82.41%27.81M-131K260.41%14.49M-105.15%-578K
Net common stock issuance --4.85M-83.41%5.29M--901K-92.91%1.13M--3.26M--0--31.88M--0--15.88M--0
Proceeds from stock option exercised by employees --0--11.19M--0--14K--10.48M--702K--0--0--0--0
Net other financing activities 66.00%-153K65.74%-1.39M112.21%16K68.49%-437K9.52%-523K77.19%-450K---4.07M---131K---1.39M---578K
Cash from discontinued financing activities
Financing cash flow 1,763.49%4.7M-45.75%15.09M800.00%917K-95.15%703K2,386.33%13.22M-98.20%252K82.41%27.81M---131K260.41%14.49M-105.15%-578K
Net cash flow
Beginning cash position -4.34%19.13M248.19%19.99M-6.69%22.06M81.26%24.6M-7.34%15.47M248.19%19.99M--5.74M247.19%23.64M88.13%13.57M--16.69M
Current changes in cash 107.47%338K-106.08%-867K19.58%-2.93M-125.24%-2.54M392.60%9.13M-141.32%-4.53M148.19%14.25M-241.80%-3.65M2,585.93%10.07M---3.12M
End cash Position 25.83%19.46M-4.34%19.13M-4.34%19.13M-6.69%22.06M81.26%24.6M-7.34%15.47M248.19%19.99M248.19%19.99M247.19%23.64M88.13%13.57M
Free cash flow 8.77%-4.36M-17.66%-15.95M-9.50%-3.85M26.67%-3.24M-60.56%-4.08M-55.30%-4.78M-42.67%-13.56M-229.52%-3.52M0.05%-4.42M36.60%-2.54M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg